BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23726846)

  • 21. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.
    Breckpot K; Escors D
    Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):328-43. PubMed ID: 19857199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.
    Zarei S; Leuba F; Arrighi JF; Hauser C; Piguet V
    J Allergy Clin Immunol; 2002 Jun; 109(6):988-94. PubMed ID: 12063529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y; Zhang J; Mi Z; Robbins P; Falo LD
    J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.
    Breckpot K; Escors D; Arce F; Lopes L; Karwacz K; Van Lint S; Keyaerts M; Collins M
    J Virol; 2010 Jun; 84(11):5627-36. PubMed ID: 20237085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.
    Lee BC; Lee J
    Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
    Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
    Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Jagged1-expressing adenovirus-infected dendritic cells induce expansion of Foxp3
    Lin CL; Huang HM; Hsieh CL; Fan CK; Lee YL
    Immunology; 2019 Feb; 156(2):199-212. PubMed ID: 30418664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of immunodeficiency viruses with dendritic cells.
    Steinman RM; Granelli-Piperno A; Pope M; Trumpfheller C; Ignatius R; Arrode G; Racz P; Tenner-Racz K
    Curr Top Microbiol Immunol; 2003; 276():1-30. PubMed ID: 12797441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways.
    Wei-guo Z; Hui Y; Shan L; Yun Z; Wen-cheng N; Fu-lin Y; Fang-yan F; Jun-hua G; Jian-hua Z
    Immunol Cell Biol; 2010; 88(3):305-12. PubMed ID: 19997078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells.
    Pen JJ; Keersmaecker BD; Heirman C; Corthals J; Liechtenstein T; Escors D; Thielemans K; Breckpot K
    Gene Ther; 2014 Mar; 21(3):262-71. PubMed ID: 24401835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
    Yim LY; Lau CS; Chan VS
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production
    Jung HJ; Park SH; Cho KM; Jung KI; Cho D; Kim TS
    Front Immunol; 2020; 11():571959. PubMed ID: 33178197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
    Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
    Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways.
    Wang JC; Felizardo TC; Au BC; Fowler DH; Dekaban GA; Medin JA
    Virol J; 2013 Jul; 10():240. PubMed ID: 23870437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters.
    Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM
    J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic Cells Exposed to Triiodothyronine Deliver Pro-Inflammatory Signals and Amplify IL-17-Driven Immune Responses.
    Alamino VA; Montesinos MDM; Soler MF; Giusiano L; Gigena N; Fozzatti L; Maller SM; Méndez-Huergo SP; Rabinovich GA; Pellizas CG
    Cell Physiol Biochem; 2019; 52(2):354-367. PubMed ID: 30816679
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Su H; Zhang Z; Liu Z; Peng B; Kong C; Wang H; Zhang Z; Xu Y
    J Biol Chem; 2018 Jun; 293(26):10287-10302. PubMed ID: 29739853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.